Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia
- PMID: 28360807
- PMCID: PMC5353039
- DOI: 10.5152/npa.2016.11327
Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia
Abstract
Introduction: Schizophrenia is a chronic illness that negatively affects the quality of life and psychosocial functions. Defined criteria to assess remission in schizophrenia are considered to be useful in the long-term follow-up of patients and in discriminating diagnostic factors. This study investigated the quality of life and functionality in schizophrenia patients in symptomatic remission (R-Sch) and not in remission (Non-R-Sch).
Methods: Sociodemographic data were collected for 40 R-Sch and 40 Non-R-Sch patients, and the following scales were administered: the Clinical Global Impression-Severity (CGI-S) Scale; Positive and Negative Syndrome Scale (PANSS), World Health Organization Quality of Life Questionnaire-Short Form, Turkish Version (WHOQOL-BREF-TR), Quality of Life Scale for Schizophrenia Patients (QLS), and Global Assessment of Functioning Scale (GAF).
Results: The total and all subscale scores of PANSS and the CGI-S score were significantly lower in the R-Sch group than in the Non-R-Sch group, whereas the GAF scores and all subscales of QLS and WHOQOL-BREF-TR were significantly higher.
Conclusion: This study demonstrates that improvement in symptoms in schizophrenia patients improves quality and functionality in all areas of life, suggesting that an improvement in symptoms is the most important determinant of functional recovery in the treatment of schizophrenia.
Keywords: Schizophrenia; quality of life; symptomatic remission.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Similar articles
-
Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders.Ann Gen Psychiatry. 2015 Feb 13;14:6. doi: 10.1186/s12991-015-0042-6. eCollection 2015. Ann Gen Psychiatry. 2015. PMID: 25699085 Free PMC article.
-
One-year functional outcomes of naturalistically treated patients with schizophrenia.Psychiatry Res. 2012 Aug 15;198(3):378-85. doi: 10.1016/j.psychres.2011.12.047. Epub 2012 Mar 14. Psychiatry Res. 2012. PMID: 22421065
-
[Social functioning and quality of life in schizophrenia patients --relationship with symptomatic remission and duration of illness].Psychiatr Pol. 2014 Mar-Apr;48(2):277-88. Psychiatr Pol. 2014. PMID: 25016765 Polish.
-
Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. J Clin Psychiatry. 1999. PMID: 10192404 Review.
-
Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.Psychiatry Res. 2015 Jun 30;227(2-3):265-9. doi: 10.1016/j.psychres.2015.02.024. Epub 2015 Apr 1. Psychiatry Res. 2015. PMID: 25882098 Review.
Cited by
-
The Association of Social Support and Symptomatic Remission among Community-Dwelling Schizophrenia Patients: A Cross-Sectional Study.Int J Environ Res Public Health. 2021 Apr 9;18(8):3977. doi: 10.3390/ijerph18083977. Int J Environ Res Public Health. 2021. PMID: 33918873 Free PMC article.
-
Real-World Functioning in Psychiatric Outpatients: Predictive Factors.J Clin Med. 2022 Jul 28;11(15):4400. doi: 10.3390/jcm11154400. J Clin Med. 2022. PMID: 35956015 Free PMC article.
-
The Factors Affecting the Relationship between Remission Status and Employment in Chronic Schizophrenia Patients.Psychiatry Investig. 2019 Nov;16(11):860-867. doi: 10.30773/pi.2019.0087. Epub 2019 Nov 6. Psychiatry Investig. 2019. PMID: 31684714 Free PMC article.
References
-
- Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinsenn R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders. Psychiatry Res. 2014;215:52–60. https://doi.org/10.1016/j.psychres.2013.10.006. - DOI - PMC - PubMed
-
- Eren İ, Şimşek D, Çalışkan AM. Şizofreni hastalarında yetiyitimi ve belirti şiddetinin yaşam kalitesine etkisi. Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi. 2007;20:68–78.
-
- Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–449. https://doi.org/10.1176/appi.ajp.162.3.441. - DOI - PubMed
-
- Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba C, Goff DC. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Res. 2008;159:140–146. https://doi.org/10.1016/j.psychres.2007.10.012. - DOI - PubMed
-
- Priebe S, McCabe R, Junghan U, Kallert T, Ruggeri M, Slade M, Reininghaus U. Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res. 2011;133:17–21. https://doi.org/10.1016/j.schres.2011.09.021. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous